Vaccine Response Impaired: Clinical Trials

33 trials for Vaccine Response Impaired, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

21 completed, 6 unknown, 3 recruiting, 2 active not recruiting. 8 Phase 4, 5 Not applicable, 2 Phase 1, 1 Early Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 48Completed 5, Active not recruiting 1, Recruiting 1, Unknown 1
Not applicable5Completed 4, Recruiting 1
Phase 12Completed 2
Early Phase 11Completed 1
Phase 21Unknown 1
Phase 31Active not recruiting 1

Follow Vaccine Response Impaired: new trials by email Literature Review of Vaccine Response Impaired trials Research Report on Vaccine Response Impaired

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Is a Third Dose of MMRV Vaccine Beneficial for the Adult Population in Alberta?
Serology for antibody levels - Baseline, Serology to assess cell mediated immune (CMI) response - Baseline, Serology for antibody levels - Post third dose of MMR vaccine - Vaccination Failure, Vaccine Response Impaired
RecruitingUniversity of Alberta2002024-11-092026-03-16
RSV Vaccine in Transplant Recipients
Adjuvant, non-live RSV vaccine - Vaccine Response Impaired, Respiratory Syncytial Virus Infections
Phase 3Active not recruitingUniversity Health Network, Toronto1002024-10-012026-10-27
Safety and Immunogenicity of Recombinant Zoster Vaccine for Transplant Recipients
Recombinant zoster vaccine adjuvanted (SHINGRIX) - Immunosuppression, Vaccine Response Impaired
Not applicableRecruitingCentral Adelaide Local Health Network Incorporated1602024-03-202026-04-09
Antibiotics and Vaccine Immune Responses Study
BCG vaccine, Yellow Fever vaccine, Vancomycin Oral Capsule - Vaccine Response Impaired
Phase 4RecruitingSouth Australian Health and Medical Research Institute3482023-11-232026-09-17
Immune Response to SARS-CoV-2/COVID-19 Vaccination in Sarcoidosis
Assay of (1) the level of anti-spike IgG antibody, and (2) interferon-gamma release in response to SARS-CoV-2 antigen stimulation - Sarcoidosis, SARS-CoV2 Infection
CompletedNorthwestern University1012021-12-012023-02-01
RECOVAC Repeated Vaccination Study
mRNA-1273, Ad26.COV2.S vaccine - Covid19, Kidney Diseases
Phase 4CompletedUniversity Medical Center Groningen3362021-10-212022-03-29
Immune Response to Third Dose of COVID-19 Vaccine in Solid Organ Transplant
Three doses of SARS-CoV-2 BNT162b2 vaccine (observational), Two doses of CoronaVac and one dose of BNT162b2 SARS-CoV-2 vaccine (observational) - COVID-19, SARS-CoV-2 Infection
CompletedPontificia Universidad Catolica de Chile1472021-10-062022-01-12
COVID19 Vaccine in SOT Adult Recipients
COVID19 mRNA vaccine - COVID-19, Vaccine Adverse Reaction
CompletedFondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico3642021-10-012024-04-02
Impact of Immunosuppression Adjustment on COVID-19 Vaccination Response in Kidney Transplant Recipients
Reduction in antimetabolite immunosuppression - COVID-19, Immunosuppression
Phase 4Active not recruitingUniversity of California, Davis142021-09-242026-04-03
Immune Response to the COVID-19 Vaccine
SARS-COV2 Pfizer Vaccine - Covid19, Cancer
Early Phase 1CompletedUniversity of Arizona202021-06-072022-05-20
Iron and COVID-19 Vaccine Response
Ferinject - Iron Deficiency Anemia, Vaccine Response Impaired
Not applicableCompletedJomo Kenyatta University of Agriculture and Technology1212021-05-292025-09-04
Iron and Vaccine Response
Ferinject - Iron Deficiency Anemia, Vaccine Preventable Disease
Not applicableCompletedSwiss Federal Institute of Technology1212021-05-292021-09-14
Third Dose of Moderna COVID-19 Vaccine in Transplant Recipients
mRNA-1273 vaccine, Normal Saline Placebo - Vaccine Response Impaired, Immune Suppression
Phase 4CompletedUniversity Health Network, Toronto1202021-05-252022-08-02
Immunogenicity of Covid-19 Vaccination for Patients With Hematological Malignancies
Immunogenicity, Hematological Malignancies
UnknownOspedale di Circolo - Fondazione Macchi3002021-04-132021-09-13
Efficacy and Safety of the Anti- COVID-19 Vaccin in Clinical Hematology Patients
Patients with hemopathy - Covid19, Hematologic Malignancy
CompletedCentre Hospitalier de Cornouaille10002021-04-012023-08-30
Vaccine Observation to Include All Communities for Equitable Science
COVID-19 vaccine - Vaccine Response Impaired, Vaccine Adverse Reaction
TerminatedPersephone Biosciences152021-04-012024-04-05
COVID-19 Vaccine Efficacy in Patients With Malignant Pathologies
Data collection - Solid Tumor, Hematologic Malignancy
UnknownAssistance Publique - Hôpitaux de Paris5002021-01-222024-01-03
Vaccination Against COVID-19 in Chronic Kidney Disease
No intervention; observational study - Chronic Kidney Disease Stage 5 on Dialysis, Chronic Kidney Disease Stage 5 With Transplant
UnknownHeinrich-Heine University, Duesseldorf4002020-12-212022-01-10
Immune Response to Seasonal Influenza Vaccination in Multiple Sclerosis Patients Receiving Cladribine
Most recent vaccine to seasonal influenza - Multiple Sclerosis, Relapsing-Remitting, Vaccine Response Impaired
UnknownHeinrich-Heine University, Duesseldorf2602020-09-012021-08-24
Heplisav-B Revaccination for Hepatitis B Vaccine Nonresponders
HIV Infections, Hepatitis B
CompletedUniversity of Maryland, Baltimore312019-10-232023-03-30

Showing 20 of 33. Sign in to see all of them.

Narrower conditions

COVID-19 (11)  ·  Hematologic Neoplasms (3)  ·  Anemia, Iron-Deficiency (2)  ·  Hepatitis B (2)  ·  Influenza, Human (2)  ·  Acquired Immunodeficiency Syndrome (1)  ·  Arthritis, Rheumatoid (1)  ·  Child Nutrition Disorders (1)  ·  Gastrointestinal Diseases (1)  ·  Growth Disorders (1)  ·  HIV Infections (1)  ·  Hepatitis (1)  ·  Hepatitis A (1)  ·  Intestinal Diseases (1)  ·  Kidney Diseases (1)

Broader conditions

Infections (19)  ·  Virus Diseases (18)  ·  RNA Virus Infections (17)  ·  Respiratory Tract Diseases (13)  ·  Respiratory Tract Infections (13)  ·  Coronaviridae Infections (11)  ·  Coronavirus Infections (11)  ·  Lung Diseases (11)  ·  Nidovirales Infections (11)  ·  Pneumonia (11)  ·  Pneumonia, Viral (11)  ·  Hemic and Lymphatic Diseases (6)  ·  Digestive System Diseases (5)  ·  Hematologic Diseases (5)  ·  Immune System Diseases (5)

Interventions

2019-nCoV Vaccine mRNA-1273 (2)  ·  Influenza Vaccines (2)  ·  Metformin (2)  ·  ferric carboxymaltose (2)  ·  Ad26COVS1 (1)  ·  Adjuvants, Pharmaceutic (1)  ·  BCG Vaccine (1)  ·  Biopsy (1)  ·  COVID-19 Vaccines (1)  ·  CVnCoV COVID-19 vaccine (1)  ·  Data Collection (1)  ·  Educational Status (1)  ·  Endoscopy, Digestive System (1)  ·  Hepatitis A Vaccines (1)  ·  Hepatitis B Vaccines (1)

Sponsors

Heinrich-Heine University, Duesseldorf (2)  ·  University Health Network, Toronto (2)  ·  University Hospital, Basel, Switzerland (2)  ·  Aga Khan University (1)  ·  Alba Maria Ropero (1)  ·  Assistance Publique - Hôpitaux de Paris (1)  ·  Central Adelaide Local Health Network Incorporated (1)  ·  Centre Hospitalier de Cornouaille (1)  ·  Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico (1)  ·  Johns Hopkins Bloomberg School of Public Health (1)  ·  Jomo Kenyatta University of Agriculture and Technology (1)  ·  Merck Sharp & Dohme LLC (1)  ·  National Taiwan University Hospital (1)  ·  Northwestern University (1)  ·  Ospedale di Circolo - Fondazione Macchi (1)

Countries

United States (8)  ·  Canada (3)  ·  Australia (2)  ·  Bangladesh (2)  ·  France (2)  ·  Germany (2)  ·  Italy (2)  ·  Kenya (2)  ·  Switzerland (2)  ·  Argentina (1)  ·  Brazil (1)  ·  Chile (1)  ·  Netherlands (1)  ·  Pakistan (1)  ·  Sweden (1)

Top investigators

Adrian Egli, PD MD (1)  ·  Benjamin Lee, M.D. (1)  ·  Chien-Ching Hung (1)  ·  Christoph T Berger, MD (1)  ·  Christopher D Heaney, PhD (1)  ·  Cristian Biscayart, MD (1)  ·  David Lynn (1)  ·  Deepali Kumar, MD (1)  ·  Denis Audet, MD (1)  ·  Francesco Passamonti, MD (1)  ·  Francois St-Maurice, MD (1)  ·  Grace Lee, PhD (1)  ·  Jan-Stephan F Sanders, MD PhD (1)  ·  Jenna M Bartley, PhD (1)  ·  Karlla Caetano, PhD (1)

Results publications

PMID 31331393, PMID 31607603, PMID 33524399, PMID 34415049, PMID 34594036, PMID 34718665, PMID 34807716, PMID 35373105, PMID 35534310, PMID 35667558, PMID 36185969, PMID 36354032, PMID 36756808, PMID 36932346, PMID 37036404, PMID 37174643, PMID 37382155, PMID 38902860, PMID 39272117